A Ser252Trp Mutation in Fibroblast Growth Factor Receptor 2 (FGFR2) Mimicking Human Apert Syndrome Reveals an Essential Role for FGF Signaling in the Regulation of Endochondral Bone Formation
Open Access
- 28 January 2014
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (1) , e87311
Abstract
A S252W mutation of fibroblast growth factor receptor 2 (FGFR2), which is responsible for nearly two-thirds of Apert syndrome (AS) cases, causes retarded development of the skeleton and skull malformation resulting from premature fusion of the craniofacial sutures. We utilized a Fgfr2+/S252W mouse (a knock-in mouse model mimicking human AS) to demonstrate decreased bone mass due to reduced trabecular bone volume, reduced bone mineral density, and shortened growth plates in the long bones. In vitro bone mesenchymal stem cells (BMSCs) culture studies revealed that the mutant mice showed reduced BMSC proliferation, a reduction in chondrogenic differentiation, and reduced mineralization. Our results suggest that these phenomena are caused by up-regulation of p38 and Erk1/2 phosphorylation. Treatment of cultured mutant bone rudiments with SB203580 or PD98059 resulted in partial rescue of the bone growth retardation. The p38 signaling pathway especially was found to be responsible for the retarded long bone development. Our data indicate that the S252W mutation in FGFR2 directly affects endochondral ossification, resulting in growth retardation of the long bone. We also show that the p38 and Erk1/2 signaling pathways partially mediate the effects of the S252W mutation of FGFR2 on long bone development.Keywords
This publication has 47 references indexed in Scilit:
- Activation of p38 MAPK pathway in the skull abnormalities of Apert syndrome Fgfr2+P253R miceBMC Developmental Biology, 2010
- Gain-of-function mutation in FGFR3 in mice leads to decreased bone mass by affecting both osteoblastogenesis and osteoclastogenesisHuman Molecular Genetics, 2010
- Gain-of-function mutation of FGFR3 results in impaired fracture healing due to inhibition of chondrocyte differentiationBiochemical and Biophysical Research Communications, 2008
- Fibroblast growth factor expression in the postnatal growth plateBone, 2007
- Fibroblast growth factor receptor 1 signaling in the osteo-chondrogenic cell lineage regulates sequential steps of osteoblast maturationDevelopmental Biology, 2006
- Impaired bone anabolic response to parathyroid hormone in Fgf2−/− and Fgf2+/− miceBiochemical and Biophysical Research Communications, 2006
- Activation of the ERK1/2 and p38 Mitogen-activated Protein Kinase Pathways Mediates Fibroblast Growth Factor-induced Growth Arrest of ChondrocytesJournal of Biological Chemistry, 2004
- A Ser250Trp substitution in mouse fibroblast growth factor receptor 2 (Fgfr2) results in craniosynostosisBone, 2003
- Increased Osteoblast Apoptosis in Apert CraniosynostosisThe American Journal of Pathology, 2001
- The Ser252Trp Fibroblast Growth Factor Receptor-2 (FGFR-2) Mutation Induces PKC-Independent Downregulation of FGFR-2 Associated with Premature Calvaria Osteoblast DifferentiationExperimental Cell Research, 2000